Buch, Englisch, 170 Seiten, Previously published in hardcover, Format (B × H): 216 mm x 279 mm, Gewicht: 1010 g
Buch, Englisch, 170 Seiten, Previously published in hardcover, Format (B × H): 216 mm x 279 mm, Gewicht: 1010 g
ISBN: 978-1-4419-2031-7
Verlag: Springer
This book is designed to complement available texts that detail percutaneous interventional procedures in cardiology. By covering the range of complications that arise, from medication related to difficulties with closure devices, this text helps physicians improve care by anticipating or recognizing problems earlier. Cardiac arrest, legal matters, and adverse event reporting are also addressed. Chapters include cases, and essential information is easily accessible in useful tables. Cardiologists, as well as interventional radiologists who perform these procedures, will appreciate the logically organized and nicely illustrated format.
Zielgruppe
Research
Autoren/Hrsg.
Fachgebiete
- Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Klinische und Innere Medizin Innere Medizin
- Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Medizinische Fachgebiete Bildgebende Verfahren, Nuklearmedizin, Strahlentherapie Radiologie, Bildgebende Verfahren
- Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Klinische und Innere Medizin Kardiologie, Angiologie, Phlebologie
- Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Klinische und Innere Medizin Geriatrie, Gerontologie
Weitere Infos & Material
Complications of the Medications.- Groin Complications.- Complications of Plain Old Balloon Angioplasty.- Coronary Guidewire Complications.- Complications Related to Coronary Stenting.- Complications of Atherectomy Devices.- The No-Reflow Phenomenon.- Early versus Late Complications.- Complications of Radiation Exposure and Therapy.- Complications of Closure Devices.- Legal Complications of Percutaneous Coronary Procedures.- Cardiac Arrest and Resuscitation During Percutaneous Coronary Interventions.- Adverse Event Reporting: Physicians, Manufacturers, and the Food and Drug Administration.
